Published in Cancer Res on December 15, 1989
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A (2001) 3.04
P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A (1998) 3.02
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets (2007) 1.82
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest (1993) 1.37
Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest (1991) 1.32
Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol (1999) 1.29
Glycosylation defining cancer cell motility and invasiveness. Glycoconj J (2004) 1.24
Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. Am J Pathol (1991) 1.16
Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer (2002) 1.05
Are selectins involved in metastasis? Clin Exp Metastasis (1999) 1.04
Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin Exp Metastasis (2002) 1.02
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One (2013) 0.97
Protein glycosylation in cancer biology: an overview. Clin Mol Pathol (1996) 0.97
Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma. Clin Exp Metastasis (2004) 0.93
Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability. Keio J Med (2010) 0.89
Characterization of a family of structurally related glycoproteins expressing beta 1-6-branched asparagine-linked oligosaccharides in human colon carcinoma cells. Biochem J (1992) 0.85
Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion. J Biol Chem (2012) 0.85
Glycosylation potential of human prostate cancer cell lines. Glycoconj J (2012) 0.85
The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer (2009) 0.84
Expression of selectin ligands by cutaneous squamous cell carcinoma. Am J Pathol (1993) 0.83
Cimetidine in colorectal cancer--are the effects immunological or adhesion-mediated? Br J Cancer (2002) 0.83
The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer. J Korean Surg Soc (2013) 0.82
Fosfomycin reduces CD15s-related antigen expression of Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 0.81
Is there a genetic signature for liver metastasis in colorectal cancer? World J Gastroenterol (2007) 0.80
Immunohistochemical expression of the sialyl Lewis x antigen on gastric cancer cells correlates with the presence of liver metastasis. Clin Exp Metastasis (1998) 0.78
Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion. Clin Exp Metastasis (1998) 0.77
Associated expression of α2,3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer. Surg Today (2012) 0.76
Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens. BMC Clin Pathol (2013) 0.75
Different expression levels of glycans on leukemic cells-a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid. Tumour Biol (2016) 0.75
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats. Eur J Nucl Med Mol Imaging (2003) 0.75
Complications and failures of subclavian-vein catheterization. N Engl J Med (1994) 9.50
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res (1995) 4.84
ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science (1990) 4.45
Molecular genetic basis of the histo-blood group ABO system. Nature (1990) 4.17
Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem (1981) 3.66
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res (1999) 3.36
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene (1999) 3.32
Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg (1992) 2.98
Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J (1983) 2.80
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75
bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res (1995) 2.56
Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med (1992) 2.52
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer (2001) 2.51
Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res (1993) 2.39
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest (1996) 2.35
CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci U S A (1991) 2.34
New cephalosporin derivatives with high antibacterial activities. Chem Pharm Bull (Tokyo) (1977) 2.33
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys (1999) 2.29
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24
New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem (1983) 2.08
MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology (1994) 2.08
Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood (1995) 2.04
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys (1995) 2.03
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg (1997) 2.01
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem (1986) 2.00
Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res (1996) 2.00
Molecular cloning and characterization of a novel human gene (HERNA) which encodes a putative RNA-helicase. Biochim Biophys Acta (2000) 1.97
Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res (1985) 1.96
Structures and organization of cell surface glycolipids dependency on cell growth and malignant transformation. Biochim Biophys Acta (1975) 1.91
ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang (1989) 1.91
Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem (1989) 1.88
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst (1992) 1.81
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett (1998) 1.78
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg (1996) 1.77
Changes in a surface-labelled galactoprotein and in glycolipid concentrations in cells transformed by a temperature-sensitive polyoma virus mutant. Nature (1974) 1.77
Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol (2002) 1.77
Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change. Semin Hematol (1981) 1.76
Tumor-associated carbohydrate antigens. Annu Rev Immunol (1984) 1.76
Domain structure of human plasma fibronectin. Differences and similarities between human and hamster fibronectins. J Biol Chem (1983) 1.71
Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst (1983) 1.71
Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem (1984) 1.70
Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (1990) 1.70
Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem (1998) 1.69
Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst (1996) 1.69
The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas (1996) 1.68
Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun (2001) 1.67
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res (1998) 1.66
Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol (1995) 1.66
Right-sided partial sternotomy for minimally invasive valve operation: "open door method". Ann Thorac Surg (1998) 1.66
Heparanases and tumor metastasis. J Cell Biochem (1988) 1.64
Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science (1983) 1.63
A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med (1984) 1.63
Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem (1984) 1.61
Functional domain structure of fibronectin. Proc Natl Acad Sci U S A (1980) 1.59
Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells. Proc Natl Acad Sci U S A (1970) 1.59
Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy. Surgery (1994) 1.59
A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun (1999) 1.56
Extramedullary plasmacytoma mimicking primary colonic carcinoma in a patient with Crohn's disease. Case report and literature review. Arch Pathol Lab Med (1996) 1.56
Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res (1988) 1.54
A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J Biol Chem (1982) 1.53
A new cell surface, detergent-insoluble glycoprotein matrix of human and hamster fibroblasts. The role of disulfide bonds in stabilization of the matrix. J Biol Chem (1981) 1.52
Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc Natl Acad Sci U S A (1992) 1.52
A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science (1983) 1.51
Cloning and molecular characterization of the gene rimL which encodes an enzyme acetylating ribosomal protein L12 of Escherichia coli K12. Mol Gen Genet (1989) 1.51
Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol (1999) 1.50
Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci U S A (1993) 1.49
The prevalence of Campylobacter pylori in gastric biopsies from cancer patients. Mod Pathol (1989) 1.48
p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res (1991) 1.48
Dietary patterns and depressive symptoms among Japanese men and women. Eur J Clin Nutr (2010) 1.46
CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res (1999) 1.46
Sialyl-Tn- and neuron-specific enolase-positive minimally differentiated erythroleukemia. Intern Med (2000) 1.46
Plasma cell granuloma of the nasal cavity treated by radiation therapy. Cancer (1991) 1.45
Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol (1998) 1.45
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg (1997) 1.44
Polyamine-promoted autoactivation of plasma hyaluronan-binding protein. J Thromb Haemost (2009) 1.44
Extramammary Paget's disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys (1992) 1.44
Exophytic signet-ring cell carcinoma of the colorectum. Arch Pathol Lab Med (1991) 1.43
The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci U S A (1985) 1.40
Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol (1993) 1.39
Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. Int J Radiat Oncol Biol Phys (1995) 1.39
Domain structure of hamster plasma fibronectin. Isolation and characterization of four functionally distinct domains and their unequal distribution between two subunit polypeptides. J Biol Chem (1981) 1.38
Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. Hum Pathol (1988) 1.37
Blood group i and I activities of "lacto-N-norhexaosylceramide" and its analogues: the structural requirements for i-specificities. Biochem Biophys Res Commun (1978) 1.37
Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry (1989) 1.37
Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp 140fms). Cell (1984) 1.37
Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest (1999) 1.36
Glycolipids of tumor cell membrane. Adv Cancer Res (1973) 1.36
Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg (1998) 1.35
Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen. Proc Natl Acad Sci U S A (1985) 1.35
Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem (1984) 1.35
Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J Biol Chem (1990) 1.35
Developmental change and genetic defect in the carbohydrate structure of band 3 glycoprotein of human erythrocyte membrane. J Biol Chem (1979) 1.35
Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg (1996) 1.35
A revised structure for the Forssman glycolipid hapten. J Biol Chem (1971) 1.34